BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...

The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

Abstract We investigated the effects of angiotensin II (Ang II) type 1 receptor blockade with losartan on the renin-angiotensin-aldosterone system in hypertensive patients (supine diastolic blood ...

Patients with chronic kidney disease who had hypertension and diabetes and received insulin therapy showed a 35% lower risk for dementia, according to published data. “Research has shown CKD to be an ...

Beyond sodium restriction, managing micronutrient intakes is important for medical nutrition therapy to control CKD, high blood pressure.

First- and second-generation potassium binders reduced potassium levels in a Swedish cohort of patients, despite premature ...

The renin-angiotensin-aldosterone system (RAAS) is a homeostatic endocrine system which is of critical importance to the regulation of blood pressure and maintenance of fluid and electrolyte balance.9 ...

Herein, we describe two cases wherein high aldosterone levels were not detected through initial segmental AVS but were identified in anomalous drainage veins during the second AVS session. In Case 1, ...

Other studies have shown that patients with post-SIT plasma aldosterone levels < 300 pmol/L and decreased aldosterone-to-renin ratio (ARR) are more likely to have idiopathic hyperaldosteronism (IHA), ...